PetVivo Holdings, Inc. (PETVW) is a publicly traded company in the Healthcare sector, operating within the Medical - Devices industry. The company is headquartered in Minneapolis, MN, United States. The current CEO is John Lai.
PETVW has IPO date of 2021-08-11, 20 full-time employees, listed on the NASDAQ Capital Marke, a market capitalization of $732.06K.
PetVivo Holdings, Inc., a veterinary biotech and biomedical device company, engages in the licensing and commercializing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Kush, a veterinarian-administered joint injection for the treatment of osteoarthritis and lameness in dogs and horses. The company's pipeline products include 17 therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. is headquartered in Minneapolis, Minnesota.
